{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:51:43Z","timestamp":1780113103819,"version":"3.54.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,26]]},"DOI":"10.7759\/cureus.88831","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T06:38:21Z","timestamp":1753598301000},"source":"Crossref","is-referenced-by-count":1,"title":["Hemophagocytic Lymphohistiocytosis: An 18-Year-Long Retrospective Single-Center Study"],"prefix":"10.7759","author":[{"given":"Madalina","family":"Bota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Colceriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Blag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna SW","year":"2020","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020, 135:1332-43. 10.1182\/blood.2019000936","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-52. 10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210041","article-title":"Approaching hemophagocytic lymphohistiocytosis","volume":"14","author":"Chinnici A","year":"2023","unstructured":"Chinnici A, Beneforti L, Pegoraro F, et al.. Approaching hemophagocytic lymphohistiocytosis. Front Immunol. 2023, 14:1210041. 10.3389\/fimmu.2023.1210041","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2022.2022-4-83","article-title":"Hemophagocytic lymphohistiocytosis","volume":"39","author":"Ka\u00e7ar AG","year":"2022","unstructured":"Ka\u00e7ar AG, Celkan TT. Hemophagocytic lymphohistiocytosis. Balkan Med J. 2022, 39:309-17. 10.4274\/balkanmedj.galenos.2022.2022-4-83","journal-title":"Balkan Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02104-w","article-title":"Hemophagocytic lymphohistiocytosis-how common and how severe is it as a complication of malaria? Retrospective case series and review of the literature","volume":"52","author":"Orth HM","year":"2024","unstructured":"Orth HM, Wiemer D, Schneitler S, et al.. Hemophagocytic lymphohistiocytosis-how common and how severe is it as a complication of malaria? Retrospective case series and review of the literature. Infection. 2024, 52:471-82. 10.1007\/s15010-023-02104-w","journal-title":"Infection"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac071","article-title":"A review of hemophagocytic lymphohistiocytosis in patients with HIV","volume":"9","author":"Tabaja H","year":"2022","unstructured":"Tabaja H, Kanj A, El Zein S, Comba IY, Chehab O, Mahmood M. A review of hemophagocytic lymphohistiocytosis in patients with HIV. Open Forum Infect Dis. 2022, 9:ofac071. 10.1093\/ofid\/ofac071","journal-title":"Open Forum Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz A","year":"2022","unstructured":"Zoref-Lorenz A, Murakami J, Hofstetter L, et al.. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022, 139:1098-110. 10.1182\/blood.2021012764","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025077","article-title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","volume":"144","author":"Henter JI","year":"2024","unstructured":"Henter JI, Sieni E, Eriksson J, et al.. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood. 2024, 144:2308-18. 10.1182\/blood.2024025077","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1901576","article-title":"Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis","volume":"14","author":"Garonzi C","year":"2021","unstructured":"Garonzi C, Chinello M, Cesaro S. Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis. Expert Rev Clin Pharmacol. 2021, 14:527-34. 10.1080\/17512433.2021.1901576","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli M","year":"2019","unstructured":"Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood. 2019, 134:1783-6. 10.1182\/blood.2019002289","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014860","article-title":"A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis","volume":"139","author":"Zhang Q","year":"2022","unstructured":"Zhang Q, Zhao YZ, Ma HH, et al.. A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood. 2022, 139:3493-504. 10.1182\/blood.2021014860","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221264","article-title":"Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV\/AIDS","volume":"2017","author":"Ocon AJ","year":"2017","unstructured":"Ocon AJ, Bhatt BD, Miller C, Peredo RA. Safe usage of anakinra and dexamethasone to treat refractory hemophagocytic lymphohistiocytosis secondary to acute disseminated histoplasmosis in a patient with HIV\/AIDS. BMJ Case Rep. 2017, 2017:bcr2017221264. 10.1136\/bcr-2017-221264","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2022.2109328","article-title":"Analysis of clinical characteristics and prognostic factors associated with EBV-associated HLH in children","volume":"27","author":"Qiu KY","year":"2022","unstructured":"Qiu KY, Guo SY, Zeng YH, Liao XY, Lin SF, Fang JP, Zhou DH. Analysis of clinical characteristics and prognostic factors associated with EBV-associated HLH in children. Hematology. 2022, 27:874-80. 10.1080\/16078454.2022.2109328","journal-title":"Hematology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0802-RA","article-title":"Hemophagocytic lymphohistiocytosis","volume":"146","author":"Ponnatt TS","year":"2022","unstructured":"Ponnatt TS, Lilley CM, Mirza KM. Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med. 2022, 146:507-19. 10.5858\/arpa.2020-0802-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2024.2436037","article-title":"Malignancy-associated HLH: mechanisms, diagnosis, and treatment of a severe hyperinflammatory syndrome","volume":"66","author":"Zoref-Lorenz A","year":"2025","unstructured":"Zoref-Lorenz A, Witzig TE, Cerhan JR, Jordan MB. Malignancy-associated HLH: mechanisms, diagnosis, and treatment of a severe hyperinflammatory syndrome. Leuk Lymphoma. 2025, 66:628-36. 10.1080\/10428194.2024.2436037","journal-title":"Leuk Lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02623-z","article-title":"Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series","volume":"109","author":"Pasvolsky O","year":"2019","unstructured":"Pasvolsky O, Zoref-Lorenz A, Abadi U, et al.. Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series. Int J Hematol. 2019, 109:553-62. 10.1007\/s12185-019-02623-z","journal-title":"Int J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.097394","article-title":"Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy","volume":"99","author":"Delavigne K","year":"2014","unstructured":"Delavigne K, B\u00e9rard E, Bertoli S, et al.. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica. 2014, 99:474-80. 10.3324\/haematol.2013.097394","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24980","article-title":"Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group","volume":"61","author":"Kogawa K","year":"2014","unstructured":"Kogawa K, Sato H, Asano T, et al.. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014, 61:1257-62. 10.1002\/pbc.24980","journal-title":"Pediatr Blood Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28386","article-title":"A case of malaria-associated hemophagocytic lymphohistiocytosis","volume":"14","author":"Almajed MR","year":"2022","unstructured":"Almajed MR, Cerna-Viacava R, Priessnitz J, Khan N, Zervos M. A case of malaria-associated hemophagocytic lymphohistiocytosis. Cureus. 2022, 14:e28386. 10.7759\/cureus.28386","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29102","article-title":"Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis\/macrophage activation syndrome in critically ill children","volume":"68","author":"Charlesworth JE","year":"2021","unstructured":"Charlesworth JE, Wilson S, Qureshi A, et al.. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis\/macrophage activation syndrome in critically ill children. Pediatr Blood Cancer. 2021, 68:e29102. 10.1002\/pbc.29102","journal-title":"Pediatr Blood Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28581","article-title":"The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis","volume":"67","author":"Bami S","year":"2020","unstructured":"Bami S, Vagrecha A, Soberman D, et al.. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020, 67:e28581. 10.1002\/pbc.28581","journal-title":"Pediatr Blood Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui N","year":"2007","unstructured":"Mahlaoui N, Ouach\u00e9e-Chardin M, de Saint Basile G, Neven B, Picard C, Blanche S, Fischer A. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics. 2007, 120:e622-8. 10.1542\/peds.2006-3164","journal-title":"Pediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386168-hemophagocytic-lymphohistiocytosis-an-18-year-long-retrospective-single-center-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T06:38:25Z","timestamp":1753598305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386168-hemophagocytic-lymphohistiocytosis-an-18-year-long-retrospective-single-center-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.88831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,26]]}}}